Xtant Medical Holdings, Inc. XMS.F Stock
Xtant Medical Holdings, Inc. Price Chart
Xtant Medical Holdings, Inc. XMS.F Financial and Trading Overview
Xtant Medical Holdings, Inc. stock price | 0.63 EUR |
Previous Close | 0.62 EUR |
Open | 0.62 EUR |
Bid | 0.62 EUR x 0 |
Ask | 0.64 EUR x 0 |
Day's Range | 0.62 - 0.62 EUR |
52 Week Range | 0.42 - 1.09 EUR |
Volume | 350 EUR |
Avg. Volume | 0 EUR |
Market Cap | 73.28M EUR |
Beta (5Y Monthly) | 0.628521 |
PE Ratio (TTM) | N/A |
EPS (TTM) | 0.01 EUR |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
XMS.F Valuation Measures
Enterprise Value | 80.12M EUR |
Trailing P/E | N/A |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 1.164008 |
Price/Book (mrq) | 2.0666666 |
Enterprise Value/Revenue | 1.273 |
Enterprise Value/EBITDA | -15.966 |
Trading Information
Xtant Medical Holdings, Inc. Stock Price History
Beta (5Y Monthly) | 0.628521 |
52-Week Change | 31.16% |
S&P500 52-Week Change | 20.43% |
52 Week High | 1.09 EUR |
52 Week Low | 0.42 EUR |
50-Day Moving Average | 0.57 EUR |
200-Day Moving Average | 0.63 EUR |
XMS.F Share Statistics
Avg. Volume (3 month) | 0 EUR |
Avg. Daily Volume (10-Days) | 0 EUR |
Shares Outstanding | 108.9M |
Float | 21.51M |
Short Ratio | N/A |
% Held by Insiders | 6.45% |
% Held by Institutions | 75.21% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | -13.26% |
Operating Margin (ttm) | -10.32% |
Gross Margin | 55.77% |
EBITDA Margin | -7.97% |
Management Effectiveness
Return on Assets (ttm) | -6.97% |
Return on Equity (ttm) | -26.93% |
Income Statement
Revenue (ttm) | 62.95M EUR |
Revenue Per Share (ttm) | 0.63 EUR |
Quarterly Revenue Growth (yoy) | 38.50% |
Gross Profit (ttm) | 32.14M EUR |
EBITDA | -5018000 EUR |
Net Income Avi to Common (ttm) | -8350000 EUR |
Diluted EPS (ttm) | -0.07 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 5.18M EUR |
Total Cash Per Share (mrq) | 0.05 EUR |
Total Debt (mrq) | 21.59M EUR |
Total Debt/Equity (mrq) | 66 EUR |
Current Ratio (mrq) | 2.118 |
Book Value Per Share (mrq) | 0.3 |
Cash Flow Statement
Operating Cash Flow (ttm) | -6582000 EUR |
Levered Free Cash Flow (ttm) | -6643000 EUR |
Profile of Xtant Medical Holdings, Inc.
Country | Germany |
State | MT |
City | Belgrade |
Address | 664 Cruiser Lane |
ZIP | 59714 |
Phone | 406 388 0480 |
Website | https://www.xtantmedical.com |
Industry | Medical Devices |
Sector(s) | Healthcare |
Full Time Employees | 134 |
Xtant Medical Holdings, Inc. develops, manufactures, and markets regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. Its biomaterial products include OsteoSponge that provides a natural scaffold for cellular in-growth and exposes bone-forming proteins to the healing environment; OsteoSponge SC that fills bony defects in the subchondral region of joints; OsteoSelect DBM Putty for osteoinductive bone growth; OsteoSelect PLUS DBM Putty for use as a bone void filler and bone graft substitute in the pelvis, extremities, and posterolateral spine; OsteoFactor, which contains various proteins and peptides that support bone formation and remodeling; OsteoWrap; and OsteoVive Plus, a growth factor enriched cellular bone matrix. The company also provides 3Demin, a family of allografts that maximizes osteoconductivity and the osteoinductive potential of human bone. In addition, it processes and distributes sports allografts for anterior and posterior cruciate ligament repairs, anterior cruciate ligament reconstruction, and meniscal repair; milled spinal allografts for cortical bone milled to desired shapes and dimensions; and traditional allografts for orthopedics, neurology, podiatry, oral/maxillofacial, genitourinary, and plastic/reconstructive applications. Further, the company offers Certex spinal fixation, Spider cervical plating, Axle interspinous fusion, Silex Sacroiliac joint fusion, Xpress minimally invasive pedicle screw, and Fortex Pedicle screw systems. Additionally, it provides Calix for cervical and thoracolumbar applications, Axle-X interspinous fusion system, Irix-C cervical integrated fusion system, and Irix-A Lumbar integrated fusion system. The company was formerly known as Bacterin International Holdings, Inc. and changed its name to Xtant Medical Holdings, Inc. in July 2015. Xtant Medical Holdings, Inc. is headquartered in Belgrade, Montana.
Q&A For Xtant Medical Holdings, Inc. Stock
What is a current XMS.F stock price?
Xtant Medical Holdings, Inc. XMS.F stock price today per share is 0.63 EUR.
How to purchase Xtant Medical Holdings, Inc. stock?
You can buy XMS.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Xtant Medical Holdings, Inc.?
The stock symbol or ticker of Xtant Medical Holdings, Inc. is XMS.F.
Which industry does the Xtant Medical Holdings, Inc. company belong to?
The Xtant Medical Holdings, Inc. industry is Medical Devices.
How many shares does Xtant Medical Holdings, Inc. have in circulation?
The max supply of Xtant Medical Holdings, Inc. shares is 136.96M.
What is Xtant Medical Holdings, Inc. Price to Earnings Ratio (PE Ratio)?
Xtant Medical Holdings, Inc. PE Ratio is 63.00000000 now.
What was Xtant Medical Holdings, Inc. earnings per share over the trailing 12 months (TTM)?
Xtant Medical Holdings, Inc. EPS is 0.01 EUR over the trailing 12 months.
Which sector does the Xtant Medical Holdings, Inc. company belong to?
The Xtant Medical Holdings, Inc. sector is Healthcare.